This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (29)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Diabetes Mellitus  • Osteoporosis  • Hypertension  • Neurology  • Alzheimer Disease  • Dementias  • Alert me on articles by topic

Daniel J. Brauner, MD; J. Cameron Muir, MD; Greg A. Sachs, MD

JAMA. 2000;283:3230-3235.

Physicians increasingly are called on to provide primary care for the growing population of people with Alzheimer-type dementia. However, little attention has been paid to the care of nondementia illnesses in this group of patients. To illustrate how presence of dementia can alter the risk-benefit ratio of treatment of a common medical problem, we present a case study in which a patient with dementia developed disastrous adverse effects to a drug commonly used to treat osteoporosis. This case and 2 composite vignettes illuminate how presence of dementia should influence the decision-making process for treatment of nondementia illnesses. We address issues such as decreased decision-making capacity, problems with reporting adverse effects, decreased cognition leading to problems with treatment adherence, and the role of screening and basic questions about acceptable burdens of treatments in patients with limited prognosis. We suggest ways to improve communication with patients with dementia in an effort to minimize complications and improve care, as well as policy changes to include patients with dementia in clinical trials.

Author Affiliations: Department of Medicine, Section of Geriatrics, and MacLean Center for Clinical Medical Ethics, The University of Chicago, Pritzker School of Medicine (Drs Brauner and Sachs) and Department of Hematology Oncology-Palliative Care, Northwestern University Medical School (Dr Muir), Chicago, Ill.

RELATED ARTICLE

June 28, 2000
JAMA. 2000;283(24):3317-3318.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Elderly Patients With Cognitive Impairment Have a High Risk for Functional Decline During Hospitalization: The GIFA Study
Pedone et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2005;60:1576-1580.
ABSTRACT | FULL TEXT  

Antibiotic Treatment and Survival of Nursing Home Patients With Lower Respiratory Tract Infection: A Cross-National Analysis
Kruse et al.
Ann Fam Med 2005;3:422-429.
ABSTRACT | FULL TEXT  

Do Statins Reduce Risk of Incident Dementia and Alzheimer Disease?: The Cache County Study
Zandi et al.
Arch Gen Psychiatry 2005;62:217-224.
ABSTRACT | FULL TEXT  

Rethinking quality in the context of persons with disability
LAWTHERS et al.
Int J Qual Health Care 2003;15:287-299.
ABSTRACT | FULL TEXT  

Withholding Antibiotic Treatment in Pneumonia Patients With Dementia: A Quantitative Observational Study
van der Steen et al.
Arch Intern Med 2002;162:1753-1760.
ABSTRACT | FULL TEXT  

Competency Issues in Dementia: Medical Decision Making, Driving, and Independent Living
Barbas and Wilde
J Geriatr Psychiatry Neurol 2001;14:199-212.
ABSTRACT